Sarentis Therapeutics Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Sarentis Therapeutics General Information

Description

Developer of therapeutics. The company engages in the development of therapeutics for the treatment of pain.

Contact Information

Formerly Known As
NOPCO
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 70 East 77th Street
  • Apartment 9C
  • New York, NY 10021
  • United States
+1 (212)
Primary Industry
Therapeutic Devices
Vertical(s)
Corporate Office
  • 70 East 77th Street
  • Apartment 9C
  • New York, NY 10021
  • United States
+1 (212)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sarentis Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jan-2018 Completed Out of Business
2. Later Stage VC 07-Jul-2015 Completed Startup
1. Seed Round 25-Nov-2009 $3.61M $3.61M Completed Startup
To view Sarentis Therapeutics’s complete valuation and funding history, request access »

Sarentis Therapeutics Patents

Sarentis Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2008225100-A1 Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing Inactive 12-Mar-2007
CA-2680704-A1 Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing Inactive 12-Mar-2007
EP-2131651-B1 Topical corneal analgesia using neurotensin receptor agonists Inactive 12-Mar-2007
EP-2131651-A1 Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing Active 12-Mar-2007
US-20150080314-A1 Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing Pending 12-Mar-2007 A61K38/08
To view Sarentis Therapeutics’s complete patent history, request access »

Sarentis Therapeutics FAQs

  • When was Sarentis Therapeutics founded?

    Sarentis Therapeutics was founded in 2005.

  • Where is Sarentis Therapeutics headquartered?

    Sarentis Therapeutics is headquartered in New York, NY.

  • What industry is Sarentis Therapeutics in?

    Sarentis Therapeutics’s primary industry is Therapeutic Devices.

  • Is Sarentis Therapeutics a private or public company?

    Sarentis Therapeutics is a Private company.

  • What is Sarentis Therapeutics’s current revenue?

    The current revenue for Sarentis Therapeutics is .

  • How much funding has Sarentis Therapeutics raised over time?

    Sarentis Therapeutics has raised $4.36M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »